• Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

  • Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

  • Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

  • Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

  • Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

  • Why do ABO incompatible kidney transplants accommodate better than HLA incompatible kidney transplants – review of immunological mechanisms

#Transplant Immunology #Asia

Live Session:

Friday, August 6, 2021 - 7:00 PM (Local time in Seoul)
Local time (Corresponding local time at your current location)

Join us:


Register

Description:


Desensitization against blood group antibodies is relatively easy and has little impact on graft survival, whereas anti-HLA antibodies are difficult to desensitize and have a negative impact on graft survival due to the increased risk of AMR. One possible cause of this is accommodation, which is defined as the absence of AMR despite the presence of antibody production in the body. However, the molecular mechanism of accommodation to anti-blood group and anti-HLA antibodies remains unclear.

Learning Objectives:


  • To learn how to use appropriate immunosuppressive drugs in ABO and HLA incompatible organ transplantation

  • To learn the molecular mechanisms of accommodation in ABO- and HLA-incompatible organ transplantation

Faculty:


Different approach in immunosuppression to ABO and HLA-incompatible organ transplantation


Robert Montgomery, USA

H. Leon Pachter Chair
Professor of Surgery
Director of the NYU Langone Transplant Institute
New York, USA

Robert A. Montgomery, MD, DPhil, FACS, is the H. Leon Pachter Chair and Professor of Surgery, Director of the NYU Langone Transplant Institute. He received his Doctor of Medicine with Honor from the University of Rochester School of Medicine.  He received his Doctor of Philosophy from Balliol College, The University of Oxford, England in Molecular Immunology.  Montgomery completed his general surgical training, multi-organ transplantation fellowship, and postdoctoral fellowship in Human Molecular Genetics at Johns Hopkins.  For over a decade he served as the Chief of Transplant Surgery and the Director of the Comprehensive Transplant Center at Johns Hopkins.

Dr. Montgomery was part of the team that developed the laparoscopic procedure for live kidney donation, a procedure that has become the standard throughout the world.  He and the Hopkins team conceived the idea of the Domino Paired Donation (kidney swaps), the Hopkins protocol for desensitization of incompatible kidney transplant patients, and performed the first chain of transplants started by an altruistic donor.  He led the team that performed the first 2-way domino paired donation, 3-way paired donation, 3-way domino paired donation, 4-way paired donation, 4-way domino paired donation, 5-way domino paired donation, 6-way domino paired donation, 8-way multi-institutional domino paired donation, and co-led the first 10-way open chain.  He is credited in the 2010 Guinness Book of World Records with the most kidney transplants performed in 1 day.   He is considered a world expert on kidney transplantation for highly sensitized and ABO incompatible patients and is referred the most complex patients from around the globe.

 

Dr. Montgomery has had clinical and basic science research supported by the NIH throughout his career.  His academic interests include HLA sensitization, tolerance protocols including simultaneous solid organ and bone marrow transplantation, and xenotransplantation.  He has received important awards and distinctions including a Fulbright Scholarship and a Thomas J. Watson Fellowship and memberships in the Phi Beta Kappa and Alpha Omega Alpha academic honor societies. He has been awarded multiple scholarships from The American College of Surgeons and The American Society of Transplant Surgeons.  The National Kidney Foundation of Maryland has recognized his contributions to the field of transplantation with the Champion of Hope Award, the National Kidney Registry with the Terasaki Medical Innovation Award and The Greater New York Hospital Association with the Profile in Courage Award.  In 2018, he became a recipient of a heart transplant from a Hepatitis C positive donor and has worked to try to promote this practice throughout the world.

Molecular mechanisms of accommodation in ABO- and HLA-incompatible organ transplantation


Hideki Ohdan, Japan

Professor
Graduate School of Biomedical and Health Sciences,

Hiroshima University
Japan

Schedule (90 min):


  • 05 min

    Welcome and introduction by the Chairs

  • 25 min

    Presentation: Different approach in immunosuppression to ABO and HLA-incompatible organ Transplantation, Robert Montgomery, USA

  • 05 min

    Live Q&A with Robert Montgomery, USA
  • 25 min

    Presentation: Molecular mechanisms of accommodation in ABO- and HLA-incompatible organ Transplantation, Hideki Ohdan, Japan

  • 05 min

    Live Q&A with Hideki Ohdan, Japan
  • 20 min

    Interactive panel discussion with audience participation led by the Chairs

  • 05 min

    Masterclass closing remarks

Join Our Mailing List


Invalid Input
Invalid Input
Invalid email address

Please select at least one of the newsletters

Ask a Question


Invalid Input
Invalid Input
Invalid email address
Please type in your question

Masterclass Prospectus Request


Submit the following information to receive the downloadable prospectus instantaneously.

Invalid Input
Invalid Input
Invalid email address
Invalid Input
Invalid Input